| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |